Vivek Rao

Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: beneficial effects of statins independent of endothelial cells.

Left ventricular reconstruction: Early and late results.

Myocardial protection in reoperative coronary artery bypass grafting:.

Charting the future by examining the past:.

Biomarkers of Inflammation, Fibrosis, and Acute Kidney Injury in Patients with Heart Failure with and without Left Ventricular Assist Device Implantation.

Changing trends in mechanical circulatory assistance:.

Hypersensitivity myocarditis complicating hypertrophic cardiomyopathy heart.

To STICH or not to STICH: we know the answer, but do we understand the question?

Combined endothelial and myocardial protection by endothelin antagonism enhances transplant allograft preservation.

Use of basiliximab and cyclosporine in heart transplant patients with pre-operative renal dysfunction.

Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule.

Tetrahydrobiopterin deficiency exaggerates intimal hyperplasia after vascular injury.

Tetrahydrobiopterin prevents cyclosporine-induced vasomotor dysfunction.

Determinants of incomplete left ventricular mass regression following aortic valve replacement for aortic stenosis.

Steroid phobia and adherence--problems, solutions, impact on benefit/risk profile.

Off-pump coronary artery surgery for reducing mortality and morbidity: meta-analysis of randomized and observational studies.

Monitoring of cyclosporine 2-hour post-dose levels in heart transplantation: improvement in clinical outcomes.

Cardiac allograft vasculopathy: a review.

Thrombosis of mechanical mitral valve prosthesis.

Elicitation of efficient, protective immune responses by using DNA vaccines against tuberculosis.

Predictors of low cardiac output syndrome after isolated aortic valve surgery.

Cardiac allograft preservation using donor-shed blood supplemented with L-arginine.

Hyperglycemia during cardiopulmonary bypass is an independent risk factor for mortality in patients undergoing cardiac surgery.

Stentless aortic valves are hemodynamically superior to stented valves during mid-term follow-up: a large retrospective study.

Stem cell transplantation for ischemic cardiomyopathy: hope or hype?

Nanoliter scale microbioreactor array for quantitative cell biology.

Aortic valve replacement: a safe and durable option in patients with impaired left ventricular systolic function.

Improving the identification of patients at risk of postoperative renal failure after cardiac surgery.

Reoperation is not an independent predictor of mortality during aortic valve surgery.

Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management.

Age before beauty: is a young marginal heart better than an older acceptable donor?

The Toronto Risk Score for adverse events following cardiac surgery.

Clinical applicability of preconditioning and postconditioning: the cardiothoracic surgeons's view.

Organ donor management in Canada: recommendations of the forum on Medical Management to Optimize Donor Organ Potential.

Condition critical: can mechanical support prevent death due to postcardiotomy shock?

Short- and long-term results of triple valve surgery in the modern era.

Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence.

Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine.

Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway.

The intricacies of cardiac sarcoidosis: a case report involving the coronary arteries and a review of the literature.

Non-utilization of hearts and lungs after consent for donation: a Canadian multicentre study.

Permanent pacing after cardiac transplantation in the era of extended donors.

Basiliximab versus rabbit anti-thymocyte globulin for induction therapy in patients after heart transplantation.

Does a pre-left ventricular assist device screening score predict long-term transplantation success? A 2-center analysis.

Canadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkers.

Early changes in bioprosthetic heart valves following ventricular assist device implantation.

Tricuspid valve replacement after cardiac transplantation.

Orthotopic cardiac transplantation in a patient with pectus excavatum: approach via left anterior thoracotomy.

Optical mapping of Langendorff-perfused human hearts: establishing a model for the study of ventricular fibrillation in humans.

Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery.

Endothelin-1 accentuates the proatherosclerotic effects associated with C-reactive protein.

Initial results of the chordal-cutting operation for ischemic mitral regurgitation.

The dilemma of a left ventricular assist device explantation: a decision analysis.

An unusual complication of support with a continuous-flow cardiac assist device.

N-acetylcysteine for preventing acute kidney injury in cardiac surgery patients with pre-existing moderate renal insufficiency.

Mycophenolate mofetil dose reduction for gastrointestinal intolerance is associated with increased rates of rejection in heart transplant patients.

Visual perception and mixed-initiative interaction for assisted visualization design.

Relation between aortic cross-clamp time and mortality--not as straightforward as expected.

Invited commentary.

Dual immunosuppression enhances vasomotor injury: interactive effect between endothelin-1 and nitric oxide bioavailability.

Mid-term outcomes of off-pump versus on-pump coronary artery bypass graft surgery.

Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.

Pathological findings in explanted prosthetic heart valves from ventricular assist devices.

Hypertrophic cardiomyopathy presenting as restrictive cardiomyopathy: a case complicated by biventricular apical aneurysms and papillary fibroelastoma.

Choices: a study of preferences for end-of-life treatments in patients with advanced heart failure.

Progesterone induces human leukocyte antigen-g expression in vascular endothelial and smooth muscle cells.

Enhanced and enduring protection against tuberculosis by recombinant BCG-Ag85C and its association with modulation of cytokine profile in lung.

Stem-cell therapy for ischaemic cardiomyopathy.

Redo valvular surgery in elderly patients.

Decreasing mortality for coronary artery bypass surgery in octogenarians.

N-acetylcysteine is associated with increased blood loss and blood product utilization during cardiac surgery.

Sex differences in resource use after on-pump and off-pump coronary artery bypass surgery: a propensity score-matched cohort.

Left ventricular device as destination therapy: are we there yet?

Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.

Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation.

Bedside ultrasound screening for pretracheal vascular structures may minimize the risks of percutaneous dilatational tracheostomy.

Donor pretreatment with hypertonic saline attenuates primary allograft dysfunction: a pilot study in a porcine model.

Everolimus but not mycophenolate mofetil therapy is associated with soluble HLA-G expression in heart transplant patients.

Surgical management of ischemic mitral regurgitation.

Effect of global ischemia and reperfusion during ventricular fibrillation in myopathic human hearts.

Boosting with a DNA vaccine expressing ESAT-6 (DNAE6) obliterates the protection imparted by recombinant BCG (rBCGE6) against aerosol Mycobacterium tuberculosis infection in guinea pigs.

Predictors of acute renal dysfunction after ventricular assist device placement.

Correlation between circulating endothelial progenitor cell function and allograft rejection in heart transplant patients.

Predictors of low cardiac output syndrome after isolated mitral valve surgery.

Association between HLA-G expression and C4d staining in cardiac transplantation.

In praise of ventricular assist devices-mechanical bridge to virtual crossmatch for the sensitized patient.

Redundant function of cmaA2 and mmaA2 in Mycobacterium tuberculosis cis cyclopropanation of oxygenated mycolates.

Impact of fixed pulmonary hypertension on post-heart transplant outcomes in bridge-to-transplant patients.

Invited commentary.

Epidermal growth factor-like domain 7 suppresses intercellular adhesion molecule 1 expression in response to hypoxia/reoxygenation injury in human coronary artery endothelial cells.

Morphological changes in porcine bioprosthetic valves of a HeartMate left ventricular assist device.

Endothelin-1 antagonism and nitric oxide augmentation prevents cyclosporine-induced vasomotor impairment.

Surgical remodeling of the left ventricle in heart failure.

Mechanical circulatory support with the ABIOMED BVS 5000: the Toronto General Hospital experience.

Tacrolimus preserves vasomotor function and maintains vascular homeostasis.

Effect of preoperative non-dialysis-dependent renal dysfunction on isolated aortic and mitral valve surgery: a propensity score analysis.

Changing trends in emergency coronary bypass surgery.

Benefits of DuraHeart™: 'a bridge to life' when treating end-stage heart disease.

The 14-bp deletion in the HLA-G gene indicates a low risk for acute cellular rejection in heart transplant recipients.

Quality of life for patients supported on a left ventricular assist device.

The effect of ventricular assist devices on long-term post-transplant outcomes: a systematic review of observational studies.

The 2011 Canadian Cardiovascular Society heart failure management guidelines update: focus on sleep apnea, renal dysfunction, mechanical circulatory support, and palliative care.

PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function.

Temporizing treatment of hyperacute subdural hemorrhage by subdural evacuation port system placement.

Changing pattern of reoperative coronary artery bypass grafting: a 20-year study.

Invited commentary.

Intramural activation during early human ventricular fibrillation.

Cardiovascular Predictors of Long-Term Outcomes After Non-Traumatic Subarachnoid Hemorrhage.

Mechanical circulatory support as a bridge to transplant candidacy.

Epidermal growth factor-like domain 7 is a novel inhibitor of neutrophil adhesion to coronary artery endothelial cells injured by calcineurin inhibition.

Human leukocyte antigen-G is upregulated in heart failure patients: a potential novel biomarker.

Historical perspectives of The American Association for Thoracic Surgery: F. Griffith Pearson (1926-).

Statin use during ischemic stroke hospitalization is strongly associated with improved poststroke survival.

Improving results for coronary artery bypass graft surgery in the elderly.

Early benefit of preserved cognitive function is not sustained at one-year after cardiac surgery: a longitudinal follow-up of the randomized controlled trial.

Are endothelial progenitor cells a prognostic factor in patients with heart failure?

Defying death: can new ECMO technology improve the outcomes of postcardiotomy shock?

Antibody-mediated rejection: an evolving entity in heart transplantation.

Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial.

Influence of baseline left ventricular function on the clinical outcome of surgical ventricular reconstruction in patients with ischaemic cardiomyopathy.

The role of extracorporeal membrane oxygenation (ECMO) therapy in acute heart failure.

Simple and reliable determination of the modified rankin scale score in neurosurgical and neurological patients: the mRS-9Q.

Detection of paroxysmal atrial fibrillation by 30-day event monitoring in cryptogenic ischemic stroke: the Stroke and Monitoring for PAF in Real Time (SMART) Registry.

Validation of the Totaled Health Risks In Vascular Events (THRIVE) score for outcome prediction in endovascular stroke treatment.

Concomitant mitral valve surgery in patients undergoing surgical ventricular reconstruction for ischaemic cardiomyopathy.

The totaled health risks in vascular events (THRIVE) score predicts ischemic stroke outcomes independent of thrombolytic therapy in the NINDS tPA trial.

Circulating proangiogenic progenitor cells independently predict functional capacity in heart failure patients.

The 2012 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: Focus on Acute and Chronic Heart Failure.

Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.

Can HLA-G polymorphisms predict the development of cardiac allograft vasculopathy?

Invited commentary.

Central sleep apnea interfering with adequate left ventricular filling in a patient with left ventricular assist device.

A simple protocol to prevent external ventricular drain infections.

Tezosentan and right ventricular failure in patients with pulmonary hypertension undergoing cardiac surgery: the TACTICS trial.

Parkinson-susceptibility gene DJ-1/PARK7 protects the murine heart from oxidative damage in vivo.

Cost-effectiveness of ventricular assist device therapy as a bridge to transplantation compared with nonbridged cardiac recipients.

Clinical differences between continuous flow ventricular assist devices: a comparison between HeartMate II and HeartWare HVAD.

One-year hemodynamic comparison of Perimount Magna with St Jude Epic aortic bioprostheses.

Chronotropic incompetence, impaired exercise capacity, and inflammation in recipients of continuous-flow left ventricular assist devices.

Integration host factor of Mycobacterium tuberculosis, mIHF, compacts DNA by a bending mechanism.

Risk modeling for ventricular assist device support in post-cardiotomy shock.

Changes in circulating progenitor cells are associated with outcome in heart failure patients: a longitudinal study.

THRIVE score predicts ischemic stroke outcomes and thrombolytic hemorrhage risk in VISTA.

Untreated preoperative depression is not associated with postoperative arrhythmias in CABG patients.

Initial experience with intraventricular repair using CorMatrix extracellular matrix.

Molecular basis of cardiac myxomas.

The 2013 Canadian Cardiovascular Society Heart Failure Management Guidelines Update: focus on rehabilitation and exercise and surgical coronary revascularization.

Transcatheter aortic valve implantation and left ventricular assist device: a word of caution.

Potential myocardial regeneration with CorMatrix ECM: a case report.

Cardiac surgery-associated acute kidney injury.

Profound hypothermia compared with moderate hypothermia in repair of acute type A aortic dissection.

Extensive tricuspid valve repair after endocarditis using CorMatrix extracellular matrix.

Fatal H1N1-Related Acute Necrotizing Encephalopathy in an Adult.

The THRIVE score strongly predicts outcomes in patients treated with the Solitaire device in the SWIFT and STAR trials.

Lessons learned from the first fully magnetically levitated centrifugal LVAD trial in the United States: the DuraHeart trial.

The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.

Early experience treating tricuspid valve endocarditis with a novel extracellular matrix cylinder reconstruction.

Native and prosthetic valve infective endocarditis: clinicopathologic correlation and review of the literature.

Markers of inflammation in recipients of continuous-flow left ventricular assist devices.

Effect of statin use during hospitalization for intracerebral hemorrhage on mortality and discharge disposition.

Transmyocardial Revascularization Enhances Bone Marrow Stem Cell Engraftment in Infarcted Hearts Through SCF-C-kit and SDF-1-CXCR4 Signaling Axes.

Multicentre Canadian experience with the HeartWare ventricular assist device: concerns about adverse neurological outcomes.

Evaluation of a novel transfusion algorithm employing point-of-care coagulation assays in cardiac surgery: a retrospective cohort study with interrupted time-series analysis.

Comprehensive review and suggested strategies for the detection and management of aortic insufficiency in patients with a continuous-flow left ventricular assist device.

The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.

Clinical outcomes of treatment by percutaneous coronary intervention versus coronary artery bypass graft surgery in patients with chronic kidney disease undergoing index revascularization in Ontario.

Factors associated with anti-human leukocyte antigen antibodies in patients supported with continuous-flow devices and effect on probability of transplant and post-transplant outcomes.

Statins and intracerebral hemorrhage--reply.

Longitudinal assessment of inflammation in recipients of continuous-flow left ventricular assist devices.

What is the best approach in a patient with a failed aortic bioprosthetic valve: transcatheter aortic valve replacement or redo aortic valve replacement?

Volatile-based short-term sedation in cardiac surgical patients: a prospective randomized controlled trial.

Historical perspectives of The American Association for Thoracic Surgery: Dr Wilfred G. Bigelow.

Prediction of intracerebral haemorrhage expansion with clinical, laboratory, pharmacologic, and noncontrast radiographic variables.

The effect of insulin to decrease neointimal growth after arterial injury is endothelial nitric oxide synthase-dependent.

Improved ischemic stroke outcome prediction using model estimation of outcome probability: the THRIVE-c calculation.

CorMatrix Extracellular Matrix Used for Valve Repair in the Adult: Is There De Novo Valvular Tissue Seen?

Resurgence of extracorporeal support for the primary management of cardiogenic shock.

In Reply.

Risks of Thrombosis and Rehemorrhage During Early Management of Intracranial Hemorrhage in Patients With Mechanical Heart Valves.

Expression profiling of lymph nodes in tuberculosis patients reveal inflammatory milieu at site of infection.

The Toronto General Hospital Transitional Pain Service: development and implementation of a multidisciplinary program to prevent chronic postsurgical pain.

To Pulse or Not to Pulse, Is That the Question?

Increased cyclic guanosine monophosphate levels and continuous-flow left-ventricular assist devices: Implications for gastrointestinal bleeding.

Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery: A Randomized Controlled Trial.

Fully Magnetically Levitated Left Ventricular Assist System for Treating Advanced HF: A Multicenter Study.

New Developments in HLA-G in Cardiac Transplantation.

Tricuspid Valve Annular Dilation as a Predictor of Right Ventricular Failure After Implantation of a Left Ventricular Assist Device.

Historical Perspectives of The American Association for Thoracic Surgery: Fredrick G. Kergin, MD (1907-1974).

Human Leukocyte Antigen-G Polymorphisms Association With Cancer Post-Heart Transplantation.

Generation of Antigen Microarrays to Screen for Autoantibodies in Heart Failure and Heart Transplantation.

Transcatheter Aortic Valve Replacement: Should Anyone Die of Aortic Stenosis Anymore?

Readmissions Following Implantation of a Continuous-Flow Left Ventricular Assist Device.

New therapy, new challenges: The effects of long-term continuous flow left ventricular assist device on inflammation.

HeartMate 3: Facing the challenge of past success.

Human leukocyte antigen G single-nucleotide polymorphism -201 (CC-CC) donor-recipient genotype matching as a predictor of severe cardiac allograft vasculopathy.

Elucidating the intricate mechanisms of gastrointestinal bleeding in a continuous-flow left ventricular assist device will lead to future therapeutic targets.

Historical perspectives of The American Association for Thoracic Surgery: Robert M. Janes, MD (1894-1966).

Multicentre clinical trial experience with the HeartMate 3 left ventricular assist device: 30-day outcomes.

Impact of Increased Early Statin Administration on Ischemic Stroke Outcomes: A Multicenter Electronic Medical Record Intervention.

Long-Term Outcomes of the Ross Procedure Versus Mechanical Aortic Valve Replacement: Propensity-Matched Cohort Study.

The tail wagging the dog: Attention to detail in valvular surgery.

Ventricular standstill in a patient with a left ventricular assist device.

Commentary: Concomitant valvular intervention at the time of ventricular assist device implant: Too much or not enough?